Skip to main content
Equibles

VAN ECK ASSOCIATES CORP

Position in CNTN — Canton Strategic Holdings, Inc.

CIK 869178 NEW YORK, NY
Back to CNTN Full portfolio

Position in CNTN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$128,885
+$25,880 QoQ
Shares Held
45,704
+45.1% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 68 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CNTN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

VAN ECK ASSOCIATES CORP holds $344,568,608 across 24 Biotechnology names. CNTN ranks #24 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 143,881 $71,470,008
2 REGN
Regeneron Pharmaceuticals, Inc.
 65,332 $40,737,114
3 RVMD
Revolution Medicines, Inc.
 111,381 $20,859,433
4 TECH
BIO-TECHNE Corp
 293,165 $20,712,105
5 ARGX
Argenx SE
 22,193 $20,589,999
6 ALNY
Alnylam Pharmaceuticals, Inc.
 58,666 $17,660,224
7 BMRN
Biomarin Pharmaceutical Inc
 307,103 $17,572,433
8 ONC
BeOne Medicines Ltd.
 55,002 $15,673,919

All Filings in CNTN

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $128,885 45,704
2026-03-31 $103,005 31,500